Literature DB >> 27596741

Nationwide epidemiological survey of childhood IgA vasculitis associated hospitalization in the USA.

Yusuke Okubo1,2,3, Kotaro Nochioka4, Hiroshi Sakakibara5, Hiroshi Hataya5, Toshiro Terakawa5, Marcia Testa4, Robert P Sundel6.   

Abstract

At the national level, IgA vasculitis-related hospitalizations among children in the USA are scarce. Furthermore, nationwide epidemiology and hospital course of children with IgA vasculitis have not been fully described in the USA, and disparities by race/ethnicity remain unknown. Hospital discharge records of patients aged 19 years or younger were obtained from the 2003, 2006, 2009, and 2012 Kids' Inpatient Database, and they were weighted to estimate the annual hospitalization rates with respect to age, gender, and race/ethnicity in the USA. Annual hospitalization rates were calculated using weighted case estimates and US census data. Negative binomial regression was used to ascertain the factors associated with length of hospital stay. Total annual hospitalization rates showed a significant decreasing trend, ranging from 2.45 per 100,000 children in 2003 to 1.89 per 100,000 children in 2012 (p < 0.001). The peak ages of the hospitalized children with IgA vasculitis were 2 and 7 years, and male-to-female ratios were 1.38-1.44. Factors associated with length of hospital stay were patients' ages (10-14 and 15-19 years), race/ethnicity (Hispanic, Asian, and Pacific Islander), comorbid electrolyte abnormality, GI hemorrhage, intussusception, renal symptoms, and GI symptoms. The annual hospitalization rates for IgA vasculitis are declining in the USA across multiple age groups. GI and renal manifestations are associated with increased length of hospital stay.

Entities:  

Keywords:  Epidemiology; IgA vasculitis; Kids’ Inpatient Database; The USA

Mesh:

Substances:

Year:  2016        PMID: 27596741     DOI: 10.1007/s10067-016-3402-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

1.  Henoch-Schönlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study.

Authors:  M C Calviño; J Llorca; C García-Porrúa; J L Fernández-Iglesias; P Rodriguez-Ledo; M A González-Gay
Journal:  Medicine (Baltimore)       Date:  2001-09       Impact factor: 1.889

2.  Long term renal prognosis of Henoch-Schönlein purpura in an unselected childhood population.

Authors:  M Stewart; J M Savage; B Bell; B McCord
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

Review 3.  A systematic review of validated methods to capture several rare conditions using administrative or claims data.

Authors:  Christopher D Lee; S Elizabeth Williams; Nila A Sathe; Melissa L McPheeters
Journal:  Vaccine       Date:  2013-12-30       Impact factor: 3.641

4.  Schonlein-Henoch purpura and Streptococcus equisimilis.

Authors:  N Cimolai; A Macnab
Journal:  Br J Dermatol       Date:  1991-10       Impact factor: 9.302

Review 5.  Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature.

Authors:  F T Saulsbury
Journal:  Medicine (Baltimore)       Date:  1999-11       Impact factor: 1.889

6.  Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study.

Authors:  Outi Jauhola; Jaana Ronkainen; Olli Koskimies; Marja Ala-Houhala; Pekka Arikoski; Tuula Hölttä; Timo Jahnukainen; Jukka Rajantie; Timo Ormälä; Matti Nuutinen
Journal:  Arch Dis Child       Date:  2010-09-16       Impact factor: 3.791

7.  Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome.

Authors:  R Blanco; V M Martínez-Taboada; V Rodríguez-Valverde; M García-Fuentes; M A González-Gay
Journal:  Arthritis Rheum       Date:  1997-05

8.  A nationwide survey on epidemiological characteristics of childhood Henoch-Schönlein purpura in Taiwan.

Authors:  Y-H Yang; C-F Hung; C-R Hsu; L-C Wang; Y-H Chuang; Y-T Lin; B-L Chiang
Journal:  Rheumatology (Oxford)       Date:  2005-01-25       Impact factor: 7.580

9.  Henoch-Schöenlein syndrome in Qatar: the effects of steroid therapy and paucity of renal involvement.

Authors:  S T Dawod; K F Akl
Journal:  Ann Trop Paediatr       Date:  1990

10.  Henoch-Schönlein purpura in Chinese children and adults.

Authors:  S J Lin; J L Huang
Journal:  Asian Pac J Allergy Immunol       Date:  1998-03       Impact factor: 2.310

View more
  4 in total

1.  The incidence and severity of IgA vasculitis with nephritis over a 10-year period in our hospital.

Authors:  Keishi Yamane; Yukihiko Kawasaki; Ryo Maeda; Shinichiro Ohara; Kazuhide Suyama; Mitsuaki Hosoya
Journal:  Fukushima J Med Sci       Date:  2017-09-14

2.  Clinical impact of endocapillary proliferation according to the Oxford classification among adults with Henoch-Schönlein purpura nephritis: a multicenter retrospective cohort study.

Authors:  Koji Inagaki; Ahmad Baseer Kaihan; Asaka Hachiya; Takaya Ozeki; Masahiko Ando; Sawako Kato; Yoshinari Yasuda; Shoichi Maruyama
Journal:  BMC Nephrol       Date:  2018-08-17       Impact factor: 2.388

Review 3.  IgA Vasculitis and IgA Nephropathy: Same Disease?

Authors:  Evangeline Pillebout
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

4.  Cutaneous vasculitis in children: A nationwide epidemiological study in Spain.

Authors:  Leyre Riancho-Zarrabeitia; Ana Santurtún
Journal:  F1000Res       Date:  2017-08-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.